Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.
D000741:Anemia, Aplastic / Q000628:therapy; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000175:diagnosis; D006086:Graft vs Host Disease / Q000175:diagnosis* / Q000401:mortality / Q000517:prevention & control; D006087:Graft vs Host Reaction; D006680:HLA Antigens; D006649:Histocompatibility Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D007945:Leukemia, Lymphoid / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use; D011828:Radiation Chimera; D012877:Skin Manifestations; D014019:Tissue Donors; D014184:Transplantation, Homologous
D006680:HLA Antigens; D006649:Histocompatibility Antigens; D003520:Cyclophosphamide; D008727:Methotrexate